Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (36,581,922) $ (31,467,850)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,670,977 4,450,361
Depreciation and amortization 493,022 578,598
Net amortization on (discount) premium of investments (426,390) 232,844
Loss on foreign exchange 12,485 829,235
Amortization of debt discount 634,011 539,867
Realized loss on investments 790 177,939
Loss on sale of property and equipment 0 21,235
Changes in operating assets and liabilities:    
(Increase) decrease in prepaid expenses and other current assets (1,376,793) 1,438,849
Increase in other assets (45,925) (86,670)
Decrease in operating lease right of use asset 606,309 535,037
Increase in other long-term liabilities 797,205 0
Increase (decrease) in accounts payable 2,527,083 (1,237,294)
Increase (decrease) in accrued expenses 1,546,529 (5,259,474)
Decrease in operating lease liabilities (948,981) (842,127)
Net cash used in operating activities (30,091,600) (30,089,450)
Cash flows from investing activities:    
Purchases of investments (30,556,135) (88,738,150)
Proceeds from sales and maturities of investments 55,809,650 107,037,899
Purchases of property and equipment 0 (13,449)
Proceeds from sale of property and equipment 0 8,100
Net cash provided by (used in) investing activities 25,253,515 18,294,400
Cash flows from financing activities:    
Repayment of short-term borrowings (353,323) (767,937)
Repayment of long-term borrowings (689,544) 0
Proceeds from issuance of common stock 244,105 0
Issuance costs paid for common stock financings (117,062) 0
Net cash used in financing activities (915,824) (767,937)
Net increase (decrease) in cash, cash equivalents, and restricted cash (5,753,909) (12,562,987)
Cash, cash equivalents, and restricted cash at beginning of the period 17,672,615 25,676,532
Cash, cash equivalents, and restricted cash at end of the period 11,918,706 13,113,545
Supplemental disclosure of cash flow information and non-cash transactions:    
Cash paid during the period for interest 1,986,399 1,407,208
Issuance of common stock for conversion of convertible debt 875,000 0
Write off of fully depreciated property and equipment $ 178,492 $ 0